Kantum Pharma Highlights New Research Demonstrating Beneficial Effects of P2Y14 Antagonist in Acute Kidney Injury
CAMBRIDGE, Mass., May 27, 2020 /PRNewswire/ -- Kantum Pharma Inc. (Kantum), a biopharmaceutical company focused...
Search for Articles
May 27, 2020
May 7, 2020
Acesion Pharma Strengthens Clinical Team with Key Appointments
Copenhagen, 5 May 2020. Acesion Pharma, a Danish pharmaceutical company developing novel treatments for atrial...
May 5, 2020
FineHeart Completes First Successful Chronic In-Vivo Study of its ICOMS Device Intended for the Treatment of Severe Heart Failure
Bordeaux, May 5, 2020 – FineHeart, a French medical device company, today announced the success...
Apr 28, 2020
AtaCor Medical Secures $25M Financing to Continue Extracardiac Pacing Development
April 28, 2020 SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. announced today that is has completed...
Mar 23, 2020
CroíValve announces successful first human use of its Duo Tricuspid Coaptation Valve technology
Dublin, Ireland, 23 March 2020 - CroíValve announced today the successful first human use of...
Feb 24, 2020
Anne Prener, M.D., Ph.D. Appointed to Renovacor Board of Directors and Scientific Advisory Board
Philadelphia, PA, February 24, 2020 – Renovacor, Inc, a preclinical-stage biopharmaceutical company focused on developing...